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ABSTRACT 
Objective: To investigate the anti-hyperlipidemic, anti-inflammatory and analgesic properties of of E. longifolia root extract in animal models.  
Methods: In this study, glucose-fructose enriched diet-induced hyperlipidemia, carrageenan-induced paw edema and acetic acid-induced writhing 
were used to evaluate the anti-hypertriglyceridemia, anti-inflammatory and analgesic activities, respectively. At the end of the experiment of 
glucose-fructose enriched diet-induced hyperlipidemia, blood samples were collected and estimation of blood lipids were carried out. Edema 
thickness was measured using digital caliper at 0, 15, 30, 45, 60, 90, 120, 150, 180, 210, 240, 270, 300, 330, and 360 min after carrageenan injection. 
The number of abdominal writhing for each mouse was observed and counted during a period of 1 h post injection of acetic acid.  
Results: E. longifolia root extract demonstrated a significant reduction of triglyceride levels (p<0.05) compared with the control group in glucose-
fructose enrich diet in rats. In anti-inflammatory test, the extract significantly inhibited the carrageenan induced paw edema formation (p<0.05). 
The extract also significantly decreased the number of writhing in acetic acid-induced mice (p<0.05).  
Conclusion: E. longifolia root extract shown a significant anti-hypertriglyceridemia, anti-inflammatory and analgesic activities. Further studies are 
needed to determine mechanisms for its acitivities of E. longifolia root extract. 
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INTRODUCTION 
Obesity and the metabolic syndrome continue to plague the world at 
an alarming rate. Those will cause both substantial socio-economic 
and physical burden in society. WHO reported that in 2014, over 1.9 
billion adults were estimated to be overweight and more than 600 
million obese [1]. 
Recently people have been using natural products and plant to treat 
a wide variety of clinical disease. One of the most popular traditional 
plants Eurycoma longifolia Jack (Simaroubaceae) is a well-known 
folklore herbal medication in Southeast Asia. Wide spectrum of 
pharmacological activities of E. longifolia has been reported [2-5]. 
Despite wide range of traditional uses known, it is most solely for its 
aphrodisiac and anti-malarial properties [5-7]. Previous research 
shows that extracts from the roots of E. longifolia suppressed 
intracellular lipid accumulation in 3T3-L1 adipocytes, a treatment 
target for an anti-obesity agent [8]. Based on the previous study and 
traditional use, the present investigation was carried out to evaluate 
the antihyperlipidemic, anti-inflammatory and analgesic activities of 
E. longifolia root extract in animal models. 
MATERIALS AND METHODS 
Plant material and chemicals  
E. longifolia was supplied by Merapi Farma Herbal Co. (Batch No. 
SL.1A.2015. PB; Yogyakarta, Indonesia) and were collected from 
Kalimantan Island Indonesia. The voucher specimen was deposited at 
the Laboratory of Pharmaceutical Biology, Faculty of Pharmacy Sanata 
Dharma University in Yogyakarta Indonesia. The following chemicals 
were used: sodium carboxy methyl cellulose/CMC-Na (Brataco 
Chemika, Indonesia); glucose, fructose, methanol and acetic acid (E. 
Merck, Darmstadt Germany; and carrageenan (Sigma Chemical 
Company). Diagnostic kit for the estimation of Cholesterol, high-
density lipoprotein cholesterol (HDL-c), low-density lipoprotein 
cholesterol (LDL-c), triglyceride (TG) kits were purchased were from 
Roche Diagnostics GmbH, Mannheim, Germany. All other chemical 
were of analytical grade and were purchased from E. Merck, 
Darmstadt, Germany. Instruments used in this study included Cobas 
C501 (Roche Diagnostics) for serum chemistry analysis. 
Preparation of E. longifolia root extract  
The root of E. longifolia were powdered and extracted with 95% 
(v/v) methanol for 48 h at room temperature. The methanol extract 
was then distilled, evaporated to obtain semisolid E. longifolia root 
extract (EL) (yield 9.32%) and re-dissolved in CMC-Na (1% w/v).  
Test animals and housing 
28 adult male Wistar rats (150-250 g), and 25 adult male and 25 
female Swiss mice (20-30 g) were obtained from the Imono 
Laboratory, Sanata Dharma University, Indonesia. The animals were 
maintained under standard laboratory condition. They were housed 
in standard cages (five animals per cage) at temperature 22 °±2 °C 
and 12:12h light dark cycle. The animals were provided with 
pelleted diet as normal diet or glucose-fructose enriched diet (GFED) 
and water ad libitium. All procedures described were reviewed and 
approved with approval number KE/KF/337/EC by Medical and 
Health Research Ethics Committee Faculty of Medicine Gadjah Mada 
University Yogyakarta Indonesia.  
Antihyperlipidemic study 
Healthy male rats were fasted overnight and randomly divided into 
four groups each containing 7 animals. The control group was fed 
normal diet until the end of treatment. The remaining groups were 
fed GFED for 42 d [9]. Following confirmation of GFED-induced 
hypertriglyceridemia, the three groups were then divided into group 
I (EL 75 mg/kg b/w), group II (EL 150 mg/kg b/w) [10], and group 
GFED-control (continued with vehicle). All treatments were 
continued for 5 d following oral administration. At the end of 
treatment, rats in all groups were anaesthetized with ketamine. The 
blood was collected from all groups of rats by retro-orbital sampling 
for serum chemistry analysis. Serum lipid profile tests were 
measured using commercial kits (Roche Diagnostics). 
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Anti-inflammatory study 
Male Swiss mice were divided into five groups randomly (negative 
control, positive control and dose groups), consisting of 5 mice in 
each group. Acute edema was induced by the injection of 
carrageenan1% (prepared in normal saline) into the sub-plantar 
region of hind-paw of mice [11]. Then, each group was treated orally 
with 1% CMC-Na (negative control), 4.48 mg/kg BW of diclofenac 
sodium (positive control), and treatment doses of 105, 210 and 420 
mg/kg BW EL [10]. Edema thickness was measured using digital 
caliper at 0, 15, 30, 45, 60, 90, 120, 150, 180, 210, 240, 270, 300, 330, 
and 360 min after carrageenan injection [12, 13]. The calculation of 
the edema volume was conducted using formula area under curve 
(AUC) and percentage of inhibition of inflammation [13-15].  
Area under curve (AUC) was calculated for each minute within 0-6 h 
using trapezoid method formula, as below:  
 [16] 
Ttn-1: Average edema volume on tn-1 
Ttn: Average edema volume on tn 
Analgesic study 
The analgesic activity of EL was tested using acetic acid-induced 
writhing method [11, 14, 15, 17]. Female mice Swiss were divided 
randomly into five groups (n=5). Group I as negative control 
received 1% CMC-Na, group II as positive control received 91 mg/kg 
BW of aspirin, group III-V received 105, 210 and 420 mg/kg BW of 
EL respectively. After 5 min of treatment, all animals were administered 
1% with 50 mg/kg BW of acetic acid intraperitoneally. The total number 
of writhes was recorded at intervals of 5 min for a period of 1 h. The 
calculation of percentage of inhibition using the following ratio: (control 
mean–treated mean)/control mean x 100 [14, 15]. 
Statistical analysis 
Results are expressed as mean±standard deviation (SD). Data were 
analyzed using one-way analysis of variance followed by post-hoc 
Tukey HSD tests using SPSS 22. A p-value<0.05 was considered 
statistically significant. Statistical differences were determined using 
the Student’s t-test, with p-values being indicated for each fig.  
RESULTS  
Effect of E. longifolia root extract in hyperlipidemia-induced 
rats 
The administration of GFED significantly increased (p<0.05) TG 
levels up to 186.1% and decreased high-density lipoprotein (HDL) 
levels by 43.0% (table 1). GFED did not increase serum total 
cholesterol or low-density lipoprotein (LDL) levels.  
Daily administration of both doses of EL for 5 d led to a significant 
reduction (p<0.05) in TG compared with the GFED group. There was 
no significant difference in HDL levels among all doses of EL and 
those of the GFED group. 
  
Table 1: Effect of E. longifolia root extract on lipid parameters in rats feeds with glucose-fructose enrich diet (GFED) 
Treatment Cholesterol (mmol/l) Triglyceride (mmol/l) HDL-c (mmol/l) LDL-c (mmol/l) 
Normal diet 1.74±0.16 1.08±0.09b 1.65±0.08b 0.21±0.05 
GFED 1.86±0.15 3.08±0.21a 0.94±0.07a 0.24±0.04 
GFED+EL 75 mg/kgBW 1.69±0.26 2.69±0.34 a,b 0.92±0.07a 0.25±0.06 
GFED+EL 150 mg/kgBW 1.88±0.17 0.43±0.05a,b 0.70±0.08a,b 0.37±0.07 a,b 
Values are expressed as mean±SD of seven animals in each group; a: p<0.05 vs normal diet; b: p<0.05 vs GFED 
 
Effect of E. longifolia root extract on carrageenan-induced mice 
The anti-inflammatory activity of E. longifolia root extract against 
carrageenan induced paw edema showed that the extracts exhibit 
significantly (p<0.05) and dose-dependently reduced the paw edema 
swelling (table 2). The percentage inhibition in the paw edema in mice 
treated with E. longifolia root extract was found to be 15.7; 22.0 and 
26.8% at the dose of 105; 210 and 420 mg/kg BW respectively.  
 
Table 2: Effect of E. longifolia root extract on carrageenan-induced mice 
Treatment AUC % inhibition 
Negative control (CMC Na) 426.7 ± 18.3b 0.0 
Positive control (diclofenac sodium 4.48 mg/kg BW) 255.9 ± 16.8a 40.0 
EL 105 mg/kg BW 359.6 ± 5.8a,b 15.7 
EL 210 mg/kg BW 333.0 ± 5.6a,b 22.0 
EL 420 mg/kg BW 312.4 ± 4.0a,b 26.8 
Values are expressed as mean±SD of five animals in each group; a: p<0.05 vs negative control; b: p<0.05 vs positive control 
 
Effect of E. longifolia root extract on acetic acid-induced 
writhing in mice 
Table 3 showed the effect of E. longifolia root extract on acetic acid-
induced writhing in mice. All of the doses of E. longifolia root extract 
produced significant (p<0.05) reduction of writhing by the acetic 
acid in a dose dependent manner.  
The percent inhibition of 105, 210 and 420 mg/kg BW was 25.4; 
57.3 and 59.0% for E. longifolia root extract respectively. 
 
Table 3: Effect of E. longifolia root extract on acetic acid induced writhing in mice 
Treatment Number of writhing % inhibition 
Negative control (CMC Na) 57.6 ± 1.1b 0.0 
Positive control (aspirin 91 mg/kgBW) 16.2 ± 1.3a 71.9 
EL 105 mg/kg BW 43.0 ± 1.0a,b 25.4 
EL 210 mg/kg BW 24.6 ± 2.1a,b 57.3 
EL 420 mg/kg BW 23.6 ± 4.2a,b 59.0 
Values are expressed as mean±SD of five animals in each group; a: p<0.05 vs negative control; b: p<0.05 vs positive control 
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DISCUSSION 
Several studies have reported that a high carbohydrate diet is 
responsible for the development of hypertriglyceridemia in rodent 
animal models [9, 18-20]. Hypertriglyceridemia occurs because high 
fructose in the blood leads to increased de novo hepatic fatty acid 
synthesis and, subsequently, this releases a high amount of TG [21]. The 
E. longifolia root extract used in our study reduced TG levels induced by 
glucose-fructose enrich diet. Therefore, the E. longifolia root extract has a 
potent anti-hypertriglyceridemia activity in rats. These reductions of TG 
may be associated with a previous in vitro report in which E. longifolia 
suppressed lipid accumulation in 3T3-L1 adipocytes [8].  
Carrageenan, as irritant substances, induced inflammation in biphasic 
event. The initial phase is associated to the release of serotonin, 
histamine, and bradykinin; while the late phase is attibuted to the 
release of prostaglandin and induce of cyclooxygenase that increasing 
vascular permeability and the neutrophil infiltration into the 
inflammatory site and production of free radicals that cause edema 
[22]. In our results, the E. longifolia root extract significantly inhibited 
paw edema-induced carrageenan in all the dose level.  
Additionally, the E. longifolia root extract showed significant 
analgesic action at all dose levels (105, 201 and 420 mg/kg BW). 
Analgesic effect was evaluated using acetic acid-induced writhing 
test in mice. Acetic acid injection has been associated with increased 
level of E and F prostaglandins in peritoneal fluids as well as 
lipoxygenase products [23]. The significant reduction of E. longifolia 
root extract might be due to the presence of analgesic principles 
acting with the prostaglandin pathways.  
It has been reported that E. longifolia contains quassinoids, 
triterpene, biphenylneolignan and alkaloid [7, 24-26]. The presence 
of eurycomaloactone, 14,15β-dihydroklaieanone and 13, 21-
dehydroeurycomanone in E. longifolia root were identified as potent 
NF-κB inhibitors [27, 28]. They act by inactivation of the NF-κB 
signaling pathway, a pro-inflammatory transcriptional factor. 
Therefore, their inhibition results in anti-inflammatory effect. Anti-
inflammatory and analgesic effects of E. longifolia root extract in this 
study are in agreement with a previous study. Han et al. 
demonstrated that methanolic extract of E. longifolia root has a 
potential analgesic agent on both heat-induced pain and chemical 
induced pain in hot plate test and acetic acid-induced writhing test, 
repectively. Methanolic extract of E. longifolia root also has anti-
inflammatory agent on carrageenan-induced paw edema [10].  
CONCLUSION 
In conclusion, we can confirm that E. longifolia root extract are 
endowed with anti-hypertriglyceridemic, anti-inflammatory and 
analgesic properties that support to the traditional use of this plant. 
However, further study is needed to investigate the mechanisms of 
pharmacological effects.  
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